A new study led by Susan G. Komen Scholars indicates that patients diagnosed with de novo stage 4 breast cancer—also called metastatic breast cancer—had improved survival rates and decreased mortality rates when those ...
Apr 11, 2022
0
44
Two Roswell Park Comprehensive Cancer Center oncologists will discuss promising strategies for making breakthrough immunotherapies work for more patients at the annual meeting of the American Association for Cancer Research ...
Apr 11, 2022
0
14
New clinical research shows that lamivudine, a reverse transcriptase inhibitor widely used in HIV therapy, stopped disease progression in 25% of patients with fourth-line metastatic colorectal cancer. Findings from the trial, ...
Apr 5, 2022
0
18
Findings from a new study performed in mice suggest that omega-3 fatty acids could help immunotherapy and other treatments do a better job at fighting cancer. Immunotherapies, which stimulate the body's own immune system ...
Apr 1, 2022
0
17
A study led by researchers from The University of Texas MD Anderson Cancer Center showed a significant overall survival benefit with ribociclib plus endocrine therapy for postmenopausal patients with hormone receptor-positive ...
Mar 9, 2022
0
11
Despite having access to health insurance, nearly three out of four patients with metastatic colorectal cancer experienced major financial hardship during the first year after their diagnosis. These are the findings of a ...
Jan 4, 2022
0
5
(HealthDay)—There were large temporal changes in screening, biopsy, overall cancer detection, and metastatic cancer rates following the 2012 U.S. Preventive Services Task Force (USPSTF) Prostate Cancer Screening Statement, ...
Dec 22, 2021
0
5
A new study has highlighted the prevalence of depression in bowel cancer patients up to five years after surgery to treat their cancer. Over a third of patients experienced clinically significant depression during the course ...
Dec 3, 2021
0
31
More people with advanced melanoma survive for two years or more when they receive a combination of two immunotherapy drugs given before a combination of two targeted therapies, if needed, compared to people who start treatment ...
Nov 15, 2021
0
10
Since 1985, cancer-related nonprofits, along with pharmaceutical firms and other businesses, have sponsored an international campaign to observe October as "Breast Cancer Awareness Month." During these weeks, the public is ...
Nov 1, 2021
0
1
